Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
AstraZeneca Nabs CinCor’s Hypertension Asset In $1.3bn Acquisition
Potential Combination With Farxiga
Jan 10 2023
•
By
Ayisha Sharma
CinCor's Asset Circumvents The Typical Cortisol Reduction Problem • Source: Shutterstock
More from Deals
More from Business